Nasus Pharma Ltd. Ordinary Shares (NSRX) SEC filings
NSRX SEC filings moved a median of +1.16% by the close. NSRX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NSRX overview →
40 measured NSRX SEC filing events.
Where these NSRX SEC filings landedvs 38 measured NSRX SEC filing reactions
| Middle 50% of NSRX SEC filing reactions | -4.55% to +5.07% |
|---|---|
| Median reaction (to close) | +1.16% |
| Measured reactions | 38 |
Point-in-time · zero look-ahead
Half of the 38 NSRX SEC filing events with a measured close landed between -4.55% and +5.07%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form S-8 Nasus Pharma Ltd | SEC filing · Form S-8 | +0.00% | +0.94% | |
| Form 6-K Nasus Pharma Ltd For: Oct 08 | SEC filing · Form 6-K | — | -3.31% | |
| Form 6-K Nasus Pharma Ltd For: Sep 18 | SEC filing · Form 6-K | — | -0.58% | |
| Form 6-K Nasus Pharma Ltd For: Sep 14 | SEC filing · Form 6-K | -3.20% | +8.31% | |
| Form EFFECT Nasus Pharma Ltd | SEC filing · Form EFFECT | -3.20% | +8.31% | |
| Form 6-K Nasus Pharma Ltd For: Sep 04 | SEC filing · Form 6-K | — | +4.02% | |
| Form F-3 Nasus Pharma Ltd | SEC filing · Form F-3 | — | +1.07% | |
| Form EFFECT Nasus Pharma Ltd | SEC filing · Form EFFECT | — | +5.26% | |
| Form 6-K Nasus Pharma Ltd For: Aug 19 | SEC filing · Form 6-K | +9.99% | +21.91% | |
| Form POS AM Nasus Pharma Ltd | SEC filing · Form POS | +9.99% | +21.91% | |
| Form 6-K Nasus Pharma Ltd For: Jun 30 | SEC filing · Form 6-K | +0.00% | +0.00% | |
| Form 6-K Nasus Pharma Ltd For: Jul 28 | SEC filing · Form 6-K | +0.56% | +2.37% | |
| Form 6-K Nasus Pharma Ltd For: Jun 09 | SEC filing · Form 6-K | +6.83% | +8.99% | |
| Form S-8 Nasus Pharma Ltd | SEC filing · Form S-8 | -0.17% | +4.50% | |
| Form EFFECT Nasus Pharma Ltd | SEC filing · Form EFFECT | +1.32% | +11.84% | |
| Form POS AM Nasus Pharma Ltd | SEC filing · Form POS | -0.90% | -9.46% | |
| Form 20-F Nasus Pharma Ltd For: Dec 31 | SEC filing · Form 20-F | +1.96% | +8.23% | |
| Form 6-K Nasus Pharma Ltd For: Mar 25 | SEC filing · Form 6-K | +3.56% | -5.14% | |
| Form 6-K Nasus Pharma Ltd For: Mar 16 | SEC filing · Form 6-K | -5.67% | -18.21% | |
| Form EFFECT Nasus Pharma Ltd | SEC filing · Form EFFECT | -5.67% | -18.21% | |
| Form 6-K Nasus Pharma Ltd For: Mar 06 | SEC filing · Form 6-K | — | -9.67% | |
| Form 6-K Nasus Pharma Ltd For: Mar 04 | SEC filing · Form 6-K | — | +0.00% | |
| Form F-1 Nasus Pharma Ltd | SEC filing · Form F-1 | — | +5.32% | |
| Form D Nasus Pharma Ltd | SEC filing · Form D | — | -7.27% | |
| Form 6-K Nasus Pharma Ltd For: Feb 23 | SEC filing · Form 6-K | — | +2.94% | |
| Form 6-K Nasus Pharma Ltd For: Feb 13 | SEC filing · Form 6-K | +0.00% | +7.08% | |
| Form 6-K Nasus Pharma Ltd For: Feb 11 | SEC filing · Form 6-K | — | — | |
| Form 6-K Nasus Pharma Ltd For: Jan 29 | SEC filing · Form 6-K | +0.00% | +2.32% | |
| Form 6-K Nasus Pharma Ltd For: Jan 20 | SEC filing · Form 6-K | +0.00% | -6.86% | |
| Form 6-K Nasus Pharma Ltd For: Jun 30 | SEC filing · Form 6-K | — | -1.32% | |
| Form 6-K Nasus Pharma Ltd For: Dec 22 | SEC filing · Form 6-K | -8.23% | -10.40% | |
| Form 6-K Nasus Pharma Ltd For: Nov 20 | SEC filing · Form 6-K | — | — | |
| Form 6-K Nasus Pharma Ltd For: Nov 18 | SEC filing · Form 6-K | +0.86% | -3.57% | |
| Form 6-K Nasus Pharma Ltd For: Nov 03 | SEC filing · Form 6-K | +0.00% | -4.88% | |
| Form 6-K Nasus Pharma Ltd For: Oct 08 | SEC filing · Form 6-K | -1.49% | +1.68% | |
| Form 6-K Nasus Pharma Ltd For: Sep 30 | SEC filing · Form 6-K | -9.42% | -10.31% | |
| Form 6-K Nasus Pharma Ltd For: Sep 05 | SEC filing · Form 6-K | +0.00% | -2.33% | |
| Form 6-K Nasus Pharma Ltd For: Aug 14 | SEC filing · Form 6-K | +0.13% | +1.25% | |
| Form EFFECT Nasus Pharma Ltd | SEC filing · Form EFFECT | +1.38% | +3.13% | |
| Form CERT Nasus Pharma Ltd | SEC filing · Form CERT | +1.38% | +3.13% |
Keep exploring
More NSRX: earnings → · analyst actions → · NSRX overview →